Neuronal cell death in neonatal hypoxia-ischemia

Annals of Neurology

Volumn 69, Issue 5, 2011, Pages 743-758

  Northington, Frances J ^a   Chavez Valdez, Raul ^b   Martin, Lee J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; HUMAN; NECROSIS; NERVE DEGENERATION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; AUTOPHAGY; CASPASES; CELL DEATH; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NECROSIS; NEURODEGENERATIVE DISEASES; NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 79955413145     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22419     Document Type: Article

References (181)

1. Folkerth RD,. Neuropathologic substrate of cerebral palsy. J Child Neurol 2005; 20: 940-949.
2. Towfighi J, Zec N, Yager J, et al. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathol 1995; 90: 375-386.
3. Myers RE,. Four patterns of perinatal brain damage and their conditions of occurrence in primates. Adv Neurol 1975; 10: 223-234.
4. Adamsons K, Myers RE,. Perinatal asphyxia, causes, detection and neurologic sequelae. Pediatr Clin North Am 1973; 20: 465-480.
5. Carloni S, Carnevali A, Cimino M, Balduini W,. Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol Dis 2007; 27: 354-361. (Pubitemid 47333193)
6. Blomgren K, Leist M, Groc L,. Pathological apoptosis in the developing brain. Apoptosis 2007; 12: 993-1010. (Pubitemid 46653298)
7. Northington FJ, Zelaya ME, O'Riordan DP, et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 2007; 149: 822-833. (Pubitemid 350130287)
8. Nakajima W, Ishida A, Lange MS, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000; 20: 7994-8004.
9. Northington FJ, Ferriero DM, Graham EM, et al. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 2001; 8: 207-219. (Pubitemid 32382476)
10. Northington FJ, Chavez-Valdez R, Graham EM, et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011; 31: 178-189.
11. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321. (Pubitemid 351550892)
12. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119.
13. Martin LJ, Brambrink AM, Price AC, et al. Neuronal death in newborn striatum after hypoxia-ischemia is necrosis and evolves with oxidative stress. Neurobiol Dis 2000; 7: 169-191. (Pubitemid 30451032)
14. Trump BF, Berezesky IK,. The role of altered [Ca2+]i regulation in apoptosis, oncosis, and necrosis. Biochim Biophys Acta 1996; 1313: 173-178. (Pubitemid 26342945)
15. Trump BF, Goldblatt PJ, Stowell RE,. Studies on necrosis of mouse liver in vitro. ultrastructural alterations in the mitochondria of hepatic parenchymal cells. Lab Invest 1965; 14: 343-371.
16. Bonfoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 1995; 92: 7162-7166.
17. Leist M, Single B, Castoldi AF, et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-1486. (Pubitemid 27187604)
18. Golden WC, Brambrink AM, Traystman RJ, Martin LJ,. Failure to sustain recovery of Na,K-ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Brain Res Mol Brain Res 2001; 88: 94-102. (Pubitemid 32274263)
19. Proskuryakov SY, Konoplyannikov AG, Gabai VL,. Necrosis: a specific form of programmed cell death? Exp Cell Res 2003; 283: 1-16. (Pubitemid 36259891)
20. Festjens N, Vanden Berghe T, Vandenabeele P,. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006; 1757: 1371-1387. (Pubitemid 44472550)
21. Kerr JF, Wyllie AH, Currie AR,. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
22. Kerr JF, Gobe GC, Winterford CM, Harmon BV,. Anatomical methods in cell death. Methods Cell Biol 1995; 46: 1-27.
23. Tata JR,. Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. Dev Biol 1966; 13: 77-94.
24. Clarke PG,. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990; 181: 195-213. (Pubitemid 20153523)
25. Lockshin RA, Zakeri Z,. Caspase-independent cell deaths. Curr Opin Cell Biol 2002; 14: 727-733. (Pubitemid 35449385)
26. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489-495.
27. Schwartz LM, Smith SW, Jones ME, Osborne BA,. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci U S A 1993; 90: 980-984. (Pubitemid 23053934)
28. Amin F, Bowen ID, Szegedi Z, et al. Apoptotic and non-apoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells. Cell Biol Int 2000; 24: 253-260.
29. Pilar G, Landmesser L,. Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 1976; 68: 339-356.
30. Portera-Cailliau C, Price DL, Martin LJ,. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 1997; 378: 88-104. (Pubitemid 27057533)
31. Portera-Cailliau C, Price DL, Martin LJ,. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol 1997; 378: 70-87. (Pubitemid 27057532)
32. Martin LJ, Al-Abdulla NA, Brambrink AM, et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46: 281-309. (Pubitemid 28294822)
33. Northington FJ, Ferriero DM, Flock DL, Martin LJ,. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001; 21: 1931-1938. (Pubitemid 32221377)
34. Klionsky DJ, Emr SD,. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721. (Pubitemid 32004796)
35. Lockshin RA, Zakeri Z,. Programmed cell death: early changes in metamorphosing cells. Biochem Cell Biol 1994; 72: 589-596.
36. Schweichel JU, Merker HJ,. The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7: 253-266.
37. Xue L, Fletcher GC, Tolkovsky AM,. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999; 14: 180-198. (Pubitemid 29449222)
38. Yue Z, Horton A, Bravin M, et al. A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice. Neuron 2002; 35: 921-933.
39. Yuan J, Lipinski M, Degterev A,. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40: 401-413. (Pubitemid 37244104)
40. Mizushima N, Ohsumi Y, Yoshimori T,. Autophagosome formation in mammalian cells. Cell Struct Funct 2002; 27: 421-429. (Pubitemid 36267711)
41. Bursch W,. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001; 8: 569-581. (Pubitemid 32590778)
42. Inbal B, Bialik S, Sabanay I, et al. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 2002; 157: 455-468. (Pubitemid 34839809)
43. Ginet V, Puyal J, Clarke PG, Truttmann AC,. Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-specific relationship to apoptotic mechanisms. Am J Pathol 2009; 175: 1962-1974.
44. Koike M, Shibata M, Tadakoshi M, et al. Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. Am J Pathol 2008; 172: 454-469. (Pubitemid 351282032)
45. Puyal J, Vaslin A, Mottier V, Clarke PG,. Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol 2009; 66: 378-389.
46. Carloni S, Buonocore G, Balduini W,. Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis 2008; 32: 329-339.
47. Johnston MV,. Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann Neurol 1983; 13: 511-518. (Pubitemid 13086669)
48. McDonald JW, Silverstein FS, Johnston MV,. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1988; 459: 200-203.
49. McDonald JW, Trescher WH, Johnston MV,. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992; 583: 54-70.
50. Choi DW,. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-1276.
51. Lipton SA, Rosenberg PA,. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
52. Olney JW,. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropathol Exp Neurol 1971; 30: 75-90.
53. van Lookeren Campagne M, Lucassen PJ, Vermeulen JP, Balazs R,. NMDA and kainate induce internucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur J Neurosci 1995; 7: 1627-1640.
54. Martin LJ,. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 1999; 58: 459-471. (Pubitemid 29220739)
55. Metzstein MM, Stanfield GM, Horvitz HR,. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 1998; 14: 410-416. (Pubitemid 28505585)
56. Cory S, Adams JM,. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656. (Pubitemid 37328916)
57. Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996; 381: 335-341.
58. Zhu C, Hallin U, Ozaki Y, et al. Nuclear translocation and calpain-dependent reduction of Bcl-2 after neonatal cerebral hypoxia-ischemia. Brain Behav Immun 2010; 24: 822-830.
59. Lok J, Martin LJ,. Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J Neurotrauma 2002; 19: 815-828. (Pubitemid 34815500)
60. Wang X, Carlsson Y, Basso E, et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci 2009; 29: 2588-2596.
61. Parsadanian AS, Cheng Y, Keller-Peck CR, et al. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998; 18: 1009-1019. (Pubitemid 28112923)
62. Gibson ME, Han BH, Choi J, et al. BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol Med 2001; 7: 644-655. (Pubitemid 34175293)
63. Ness JM, Harvey CA, Strasser A, et al. Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res 2006; 1099: 150-159. (Pubitemid 44088651)
64. Wolf BB, Green DR,. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 1999; 274: 20049-20052.
65. Stennicke HR, Deveraux QL, Humke EW, et al. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359-8362. (Pubitemid 29164620)
66. Schwartz LM, Milligan CE,. Cold thoughts of death: the role of ICE proteases in neuronal cell death. Trends Neurosci 1996; 19: 555-562. (Pubitemid 26390176)
67. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489. (Pubitemid 27508237)
68. Zou H, Li Y, Liu X, Wang X,. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-11556.
69. Liu X, Zou H, Slaughter C, Wang X,. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-184. (Pubitemid 27199890)
70. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-157. (Pubitemid 26256586)
71. Li H, Zhu H, Xu CJ, Yuan J,. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501. (Pubitemid 28391865)
72. Hu BR, Liu CL, Ouyang Y, et al. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000; 20: 1294-1300.
73. Wang X, Karlsson JO, Zhu C, et al. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol Neonate 2001; 79: 172-179. (Pubitemid 32247082)
74. Zhu C, Qiu L, Wang X, et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003; 86: 306-317. (Pubitemid 36842430)
75. Robertson JD, Enoksson M, Suomela M, et al. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803-29809.
76. Kaindl AM, Sifringer M, Koppelstaetter A, et al. Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes. Ann Neurol 2008; 64: 523-534.
77. Blomgren K, Zhu C, Wang X, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia- ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 2001; 276: 10191-10198.
78. Felderhoff-Mueser U, Sifringer M, Pesditschek S, et al. Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis 2002; 11: 231-245. (Pubitemid 36135688)
79. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999. (Pubitemid 28226119)
80. Delivoria-Papadopoulos M, Ashraf QM, Ara J, Mishra OP,. Nuclear mechanisms of hypoxic cerebral injury in the newborn: the role of caspases. Semin Perinatol 2008; 32: 334-343.
81. Zhu C, Wang X, Xu F, et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005; 12: 162-176. (Pubitemid 40220647)
82. Lesuisse C, Martin LJ,. Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab 2002; 22: 935-950. (Pubitemid 34831600)
83. Feng Y, LeBlanc MH,. Treatment of hypoxic-ischemic brain injury in newborn rats with TPCK 3 h after hypoxia decreases caspase-9 activation and improves neuropathologic outcome. Dev Neurosci 2003; 25: 34-40. (Pubitemid 36921048)
84. Feng Y, Fratkin JD, LeBlanc MH,. Inhibiting caspase-9 after injury reduces hypoxic ischemic neuronal injury in the cortex in the newborn rat. Neurosci Lett 2003; 344: 201-204. (Pubitemid 36694678)
85. Feng Y, Fratkin JD, LeBlanc MH,. Inhibiting caspase-8 after injury reduces hypoxic-ischemic brain injury in the newborn rat. Eur J Pharmacol 2003; 481: 169-173. (Pubitemid 37464966)
86. Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ 2003; 10: 881-888. (Pubitemid 36939698)
87. Ostwald K, Hagberg H, Andine P, Karlsson JO,. Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res 1993; 630: 289-294. (Pubitemid 23342852)
88. Kawamura M, Nakajima W, Ishida A, et al. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 2005; 1037: 59-69. (Pubitemid 40372099)
89. Han Y, Giroux A, Colucci J, et al. Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg Med Chem Lett 2005; 15: 1173-1180. (Pubitemid 40458668)
90. Han BH, Xu D, Choi J, et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 2002; 277: 30128-30136.
91. West T, Atzeva M, Holtzman DM,. Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiol Dis 2006; 22: 523-537. (Pubitemid 43832124)
92. Beresford PJ, Zhang D, Oh DY, et al. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem 2001; 276: 43285-43293.
93. Fan Z, Beresford PJ, Oh DY, et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112: 659-672. (Pubitemid 36331778)
94. Gulyaeva NV,. Non-apoptotic functions of caspase-3 in nervous tissue. Biochemistry (Mosc) 2003; 68: 1171-1180.
95. Lu C, Fu W, Salvesen GS, Mattson MP,. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med 2002; 1: 69-79. (Pubitemid 37021525)
96. Yan XX, Najbauer J, Woo CC, et al. Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain. J Comp Neurol 2001; 433: 4-22.
97. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T,. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010; 3: re4.
98. Graham EM, Sheldon RA, Flock DL, et al. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis 2004; 17: 89-98. (Pubitemid 39209316)
99. Dzietko M, Boos V, Sifringer M, et al. A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann Neurol 2008; 64: 664-673.
100. Levrero M, De Laurenzi V, Costanzo A, et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 2000; 113 (Pt 10): 1661-1670. (Pubitemid 30333115)
101. Martin LJ, Chen K, Liu Z,. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J Neurosci 2005; 25: 6449-6459. (Pubitemid 40962540)
102. Tan Z, Levid J, Schreiber SS,. Increased expression of Fas (CD95/APO-1) in adult rat brain after kainate-induced seizures. Neuroreport 2001; 12: 1979-1982. (Pubitemid 32553718)
103. van Lookeren C, Gill R,. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax. J Comp Neurol 1998; 397: 181-198. (Pubitemid 28303354)
104. Nijboer CH, Heijnen CJ, Groenendaal F, et al. A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008; 39: 2578-2586.
105. Martin LJ, Kaiser A, Yu JW, et al. Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax. J Comp Neurol 2001; 433: 299-311. (Pubitemid 32280653)
106. Martin LJ, Liu Z,. Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53- and Bax-dependent. J Neurobiol 2002; 50: 181-197. (Pubitemid 34131050)
107. Calvert JW, Cahill J, Yamaguchi-Okada M, Zhang JH,. Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol 2006; 101: 853-865. (Pubitemid 44352300)
108. Nijboer CH, Heijnen CJ, Groenendaal F, et al. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008; 39: 2129-2137.
109. Natale JE, Cheng Y, Martin LJ,. Thalamic neuron apoptosis emerges rapidly after cortical damage in immature mice. Neuroscience 2002; 112: 665-676. (Pubitemid 34634160)
110. Martin LJ,. Neuronal cell death in nervous system development, disease, and injury (Review). Int J Mol Med 2001; 7: 455-478.
111. Sheldon RA, Hall JJ, Noble LJ, Ferriero DM,. Delayed cell death in neonatal mouse hippocampus from hypoxia-ischemia is neither apoptotic nor necrotic. Neurosci Lett 2001; 304: 165-168. (Pubitemid 32436402)
112. Dobbing J, Sands J,. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79-83. (Pubitemid 9141710)
113. Rothstein RP, Levison SW,. Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults. Dev Neurosci 2005; 27: 149-159. (Pubitemid 41096221)
114. Mueller D, Shamblott MJ, Fox HE, et al. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. J Neurosci Res 2005; 82: 592-608. (Pubitemid 41740460)
115. Martin LJ, Brambrink AM, Lehmann C, et al. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 1997; 42: 335-348. (Pubitemid 27391117)
116. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G,. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752. (Pubitemid 47312826)
117. Ferriero DM,. Timing is everything-delaying therapy for delayed cell death. Dev Neurosci 2002; 24: 349-351. (Pubitemid 36359364)
118. Orrenius S, Zhivotovsky B, Nicotera P,. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-565. (Pubitemid 36773407)
119. Yamashima T,. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62: 273-295. (Pubitemid 30326777)
120. Joly LM, Mucignat V, Mariani J, et al. Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 2004; 24: 124-131. (Pubitemid 38021276)
121. Nakagawa T, Yuan J,. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000; 150: 887-894. (Pubitemid 30663424)
122. Fischer H, Koenig U, Eckhart L, Tschachler E,. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002; 293: 722-726. (Pubitemid 34687247)
123. Scorrano L, Oakes SA, Opferman JT, et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003; 300: 135-139. (Pubitemid 36423046)
124. Chen Y, Lewis W, Diwan A, et al. Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy. Proc Natl Acad Sci U S A 2010; 107: 9035-9042.
125. Lin Y, Devin A, Rodriguez Y, Liu ZG,. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999; 13: 2514-2526. (Pubitemid 29489643)
126. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P,. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14: 400-410.
127. Temkin V, Huang Q, Liu H, et al. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 2006; 26: 2215-2225. (Pubitemid 43346922)
128. Martin LJ,. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy. Biochim Biophys Acta 2010; 1802: 186-197.
129. Lian J, Wu X, He F, et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 2011; 18: 60-71.
130. Ogier-Denis E, Codogno P,. Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603: 113-128. (Pubitemid 36266686)
131. Yu L, Lenardo MJ, Baehrecke EH,. Autophagy and caspases: a new cell death program. Cell Cycle 2004; 3: 1124-1126. (Pubitemid 40268628)
132. Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304: 1500-1502. (Pubitemid 38720930)
133. Martin LJ, Portera-Cailliau C, Ginsberg SD, Al-Abdulla NA,. Animal models and degenerative disorders of the human brain. Lab Animal 1998; 27: 18-25.
134. Bialik S, Zalckvar E, Ber Y, et al. Systems biology analysis of programmed cell death. Trends Biochem Sci 2010; 35: 556-564.
135. Martin LJ,. The apoptosis-necrosis cell death continuum in CNS development, injury and disease: contributions and mechanisms. In:, Lo EH, Marwah J, eds. Neuroprotection. Boston: Prominent Press, 2002: 379-412.
136. Crompton M,. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341 (Pt 2): 233-249. (Pubitemid 29373645)
137. Zhu C, Xu F, Wang X, et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 2006; 96: 1016-1027.
138. Martin LJ, Gertz B, Pan Y, et al. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol 2009; 218: 333-346.
139. Martin LJ, Kaiser A, Price AC,. Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J Neurobiol 1999; 40: 185-201. (Pubitemid 29343303)
140. Baines CP, Kaiser RA, Purcell NH, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434: 658-662. (Pubitemid 40488559)
141. Martin LJ, Liu Z, Chen K, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol 2007; 500: 20-46. (Pubitemid 44904300)
142. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-336.
143. Liu Z, Martin LJ,. Isolation of mature spinal motor neurons and single-cell analysis using the comet assay of early low-level DNA damage induced in vitro and in vivo. J Histochem Cytochem 2001; 49: 957-972. (Pubitemid 32675003)
144. Strozyk E, Poppelmann B, Schwarz T, Kulms D,. Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 2006; 25: 6239-6251. (Pubitemid 44564741)
145. Ishimaru MJ, Ikonomidou C, Tenkova TI, et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 1999; 408: 461-476. (Pubitemid 29211175)
146. Henriquez M, Armisen R, Stutzin A, Quest AF,. Cell death by necrosis, a regulated way to go. Curr Mol Med 2008; 8: 187-206. (Pubitemid 351982538)
147. Bredesen DE,. Programmed cell death mechanisms in neurological disease. Curr Mol Med 2008; 8: 173-186. (Pubitemid 351982537)
148. Nagley P, Higgins GC, Atkin JD, Beart PM,. Multifaceted deaths orchestrated by mitochondria in neurones. Biochim Biophys Acta 2010; 1802: 167-185.
149. You Z, Savitz SI, Yang J, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008; 28: 1564-1573.
150. Lim SY, Davidson SM, Mocanu MM, et al. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc Drugs Ther 2007; 21: 467-469. (Pubitemid 350231514)
151. Berghe TV, Vanlangenakker N, Parthoens E, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010; 17: 922-930.
152. Shen HM, Pervaiz S,. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006; 20: 1589-1598. (Pubitemid 44943796)
153. Eguchi Y, Shimizu S, Tsujimoto Y,. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997; 57: 1835-1840. (Pubitemid 27209706)
154. Leist M, Jaattela M,. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-598. (Pubitemid 33674010)
155. Leist M, Single B, Naumann H, et al. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res 1999; 249: 396-403. (Pubitemid 29397947)
156. Micheau O, Tschopp J,. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190. (Pubitemid 36936912)
157. Vandenabeele P, Vanden Berghe T, Festjens N,. Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006;2006: pe44
158. Davis CW, Hawkins BJ, Ramasamy S, et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic Biol Med 2010; 48: 306-317.
159. Xu X, Chua CC, Kong J, et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 2007; 103: 2004-2014. (Pubitemid 350126615)
160. Smith CC, Davidson SM, Lim SY, et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 2007; 21: 227-233. (Pubitemid 47387468)
161. Hsu TS, Yang PM, Tsai JS, Lin LY,. Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol Appl Pharmacol 2009; 235: 153-162.
162. Shen HM, Lin Y, Choksi S, et al. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol 2004; 24: 5914-5922. (Pubitemid 38787975)
163. Kim YS, Morgan MJ, Choksi S, Liu ZG,. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26: 675-687. (Pubitemid 46856240)
164. Vercammen D, Brouckaert G, Denecker G, et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998; 188: 919-930. (Pubitemid 28433418)
165. Elder DE, Zuccollo JM, Stanley TV,. Neonatal death after hypoxic ischaemic encephalopathy: does a postmortem add to the final diagnoses? BJOG 2005; 112: 935-940. (Pubitemid 40896960)
166. Barkovich AJ, Westmark KD, Bedi HS, et al. Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report. AJNR Am J Neuroradiol 2001; 22: 1786-1794. (Pubitemid 32999596)
167. Takizawa Y, Takashima S, Itoh M,. A histopathological study of premature and mature infants with pontosubicular neuron necrosis: neuronal cell death in perinatal brain damage. Brain Res 2006; 1095: 200-206. (Pubitemid 43866028)
168. Meng SZ, Ohyu J, Takashima S,. Changes in AMPA glutamate and dopamine D2 receptors in hypoxic-ischemic basal ganglia necrosis. Pediatr Neurol 1997; 17: 139-143. (Pubitemid 27465181)
169. Taniguchi H, Mohri I, Okabe-Arahori H, et al. Early induction of neuronal lipocalin-type prostaglandin D synthase after hypoxic-ischemic injury in developing brains. Neurosci Lett 2007; 420: 39-44. (Pubitemid 46777099)
170. Zhengyu Z, Zhimou X, Yubin W, et al. Defibrillation and resuscitation in a piglet model of pediatric ventricular fibrillation following AHA 2005 Guidelines. Indian J Pediatr 2010, Aug 26. Epub ahead of print. DOI 10.1007/s12098-010-0128-8.
171. Martin LJ, Brambrink AM, Koehler RC, Traystman RJ,. Primary sensory and forebrain motor systems in the newborn brain are preferentially damaged by hypoxia-ischemia. J Comp Neurol 1997; 377: 262-285. (Pubitemid 27009833)
172. Glauser EM,. Advantages of piglets as experimental animals in pediatric research. Exp Med Surg 1966; 24: 181-190.
173. Lind NM, Moustgaard A, Jelsing J, et al. The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev 2007; 31: 728-751. (Pubitemid 46680451)
174. Brambrink AM, Ichord RN, Martin LJ, et al. Poor outcome after hypoxia-ischemia in newborns is associated with physiological abnormalities during early recovery. Possible relevance to secondary brain injury after head trauma in infants. Exp Toxicol Pathol 1999; 51: 151-162. (Pubitemid 29131684)
175. Mueller-Burke D, Koehler RC, Martin LJ,. Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia. Int J Dev Neurosci 2008; 26: 67-76. (Pubitemid 351192266)
176. Yang ZJ, Carter EL, Torbey MT, et al. Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 2010; 221: 166-174.
177. Johnston MV,. Selective vulnerability in the neonatal brain. Ann Neurol 1998; 44: 155-156. (Pubitemid 28374100)
178. Yang ZJ, Torbey M, Li X, et al. Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets. J Cereb Blood Flow Metab 2007; 27: 1339-1351. (Pubitemid 46985351)
179. Formigli L, Papucci L, Tani A, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000; 182: 41-49. (Pubitemid 129710498)
180. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135: 1311-1323.
181. Ohmura A, Nakajima W, Ishida A, et al. Prolonged hypothermia protects neonatal rat brain against hypoxic-ischemia by reducing both apoptosis and necrosis. Brain Dev 2005; 27: 517-526. (Pubitemid 41383493)